ArticleOPEN ACCESS

Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin

Haematologica
DOI: 10.3324/haematol.2021.278894
9Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Teich, K., Krzykalla, J., Kapp-Schwoerer, S., Gaidzik, V. I., Schlenk, R. F., Paschka, P., … Thol, F. (2021, November 1). Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin. Haematologica. Ferrata Storti Foundation. https://doi.org/10.3324/haematol.2021.278894

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free